PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954619
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954619
The global sleeping bruxism treatment market was valued at USD 448.01 million in 2025 and is projected to grow to USD 477.35 million in 2026, reaching USD 825.8 million by 2034, representing a CAGR of 7.09% during the forecast period. North America dominated the market in 2025 with a 36.08% share, equivalent to USD 161.65 million, driven by high adult prevalence rates, widespread awareness, and a dense network of dental professionals.
Sleep bruxism is a disorder characterized by involuntary teeth clenching or grinding during sleep, which can cause headaches, jaw pain, and dental wear. The market growth is driven by rising anxiety, stress, sleep disorders, and obstructive sleep apnea, which increase bruxism risk. The expanding availability of treatment options through hospitals, clinics, and online pharmacies also contributes to market expansion.
Market Dynamics
Drivers
The prevalence of sleep bruxism is increasing globally. Studies, such as one from Chulalongkorn University in March 2023, indicate that approximately 49.7% of adults with obstructive sleep apnea exhibit sleep bruxism. Growing public awareness, rising demand for non-invasive treatments like mouth guards and splints, and improved diagnostic technologies are boosting the adoption of bruxism treatment solutions worldwide.
Restraints
Despite high prevalence, actual treatment adoption remains limited due to underreporting, low awareness, and lack of universally accepted therapeutic options. For example, a 2020 study in Turkey reported that only 3.8% of parents sought treatment for their children's bruxism, highlighting the gap between prevalence and treatment usage, which is restricting market growth.
Opportunities
Smart mouth guards with biofeedback features are emerging as a major growth opportunity. These devices monitor jaw activity, provide real-time feedback, and train patients to reduce grinding episodes. According to the Cleveland Clinic in October 2023, Prevent Biometrics' Intelligent Mouthguard captures jaw movements and transmits data wirelessly, providing precise measurements for preventive therapy.
Market Trends
Advances in custom-fit and 3D printing technologies are transforming bruxism treatment. 3D printing allows for precise digital fabrication of mouth guards, enhancing comfort, fit, and durability. Integration with sensors enables smart mouth guards that monitor jaw activity while offering real-time feedback, increasing adoption among adults, athletes, and patients with severe bruxism.
Market Challenges
Alternative treatment options, including behavioral therapies, Botox injections, and muscle relaxants, are reducing demand for device-based treatments. Regulatory hurdles for new devices can further delay market entry and limit adoption. According to NCBI (July 2023), Botulinum toxin injections are effective for patients unresponsive to conventional therapies, highlighting competition with traditional mouth guard solutions.
By Product Type: The market is divided into mouth guards, splints, and others. The mouth guards segment led in 2026 with a 51.79% share, due to OTC availability, affordability, and custom-fitted designs. For example, in November 2023, Quip launched custom-fit Quip Night Guards, expanding professional-grade solutions to consumers.
By Patient Type: Adults dominate the market, holding 76.15% share in 2026, due to higher prevalence of temporomandibular disorders (TMD), headaches, and cracked teeth. The pediatric segment is projected to grow at a CAGR of 6.4%.
By End-User: Dental clinics dominated in 2025, maintaining 41.59% share in 2026, as most custom devices are prescribed and fitted by dentists. Homecare is projected to grow at a CAGR of 6.8% as OTC and smart devices gain traction.
Competitive Landscape
The market is moderately consolidated with key players including SomnoMed, Procter & Gamble (Plackers), Dentsply Sirona, Smile Brilliant, Ivoclar Vivadent, Henry Schein, Quip, Sunstar Group, and ResMed. Strategic initiatives focus on customized devices, innovative materials, digital fabrication, partnerships with dental providers, and online channel expansion.
Recent Developments:
Conclusion
The global sleeping bruxism treatment market, valued at USD 448.01 million in 2025, is projected to grow to USD 477.35 million in 2026 and USD 825.8 million by 2034, at a CAGR of 7.09%. Market growth is supported by rising prevalence of bruxism, increasing awareness, technological advancements in smart and 3D-printed devices, and expanding dental infrastructure. While limited treatment adoption and alternative therapies pose challenges, innovations in personalized solutions and the growing adult patient population are expected to sustain market expansion through 2034.
Segmentation By Product Type, Patient Type, End-user, and Region
By Product Type * Mouth Guards
By Patient Type * Adults
By End-user * Hospitals
By Region * North America (By Product Type, Patient Type, End-user, and Country)